Find key clinical documentation and medical coding information for Kawasaki Disease. Learn about Kawasaki Disease diagnosis criteria, ICD-10 code (M30.3), symptoms, treatment, and healthcare management. This resource provides essential information for physicians, nurses, and other healthcare professionals involved in the diagnosis and care of patients with Kawasaki Disease. Explore accurate and up-to-date medical coding guidelines for proper documentation and billing.
Also known as
Kawasaki disease
Inflammation of blood vessels, mainly in children.
Arteritis, unspecified
Inflammation of arteries, without further specification.
Coronary artery disease, unspecified
Disease of the arteries of the heart, unspecified.
Mucocutaneous lymph node syndrome
Another term for Kawasaki disease, with prominent lymph node involvement.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is diagnosis Kawasaki Disease?
Yes
With coronary artery aneurysm?
No
Do not code Kawasaki Disease. Evaluate for other diagnoses.
When to use each related code
| Description |
|---|
| Fever, rash, swollen lymph nodes |
| Fever, rash, joint pain |
| Viral infection with rash |
Insufficient clinical criteria documented to support Kawasaki Disease diagnosis, leading to coding errors and potential denials.
Missing documentation specifying acute, subacute, or convalescent phase impacting accurate code assignment and reimbursement.
Presence of similar conditions like scarlet fever or viral infections creating diagnostic confusion and coding ambiguity.
Patient presents with a chief complaint of persistent high fever (Kawasaki fever, Kawasaki syndrome), unresponsive to antipyretics, exceeding five days duration. Associated symptoms include bilateral conjunctival injection without exudate, erythema of the oral mucosa (strawberry tongue), cracked lips, and cervical lymphadenopathy (greater than 1.5 cm diameter). The patient also exhibits polymorphous exanthema involving the trunk and extremities. Peripheral extremity changes are noted, including erythema and edema of the hands and feet, followed by periungual desquamation. No other apparent source of infection identified. Differential diagnosis includes scarlet fever, measles, drug reaction, and juvenile idiopathic arthritis. Based on clinical presentation and fulfillment of the American Heart Association diagnostic criteria for Kawasaki disease, a diagnosis of Kawasaki disease is made. Initial laboratory studies revealed elevated inflammatory markers, including CRP and ESR. Echocardiogram ordered to assess for coronary artery abnormalities. Treatment plan includes intravenous immunoglobulin (IVIG) therapy and high-dose aspirin therapy initiated to reduce inflammation and prevent coronary artery complications. Patient will be closely monitored for response to therapy and development of potential complications such as coronary artery aneurysms. Follow-up appointments scheduled for cardiac monitoring and evaluation of treatment efficacy. ICD-10 code M30.30 specified for Kawasaki disease without coronary artery aneurysm. Appropriate medical billing codes for IVIG administration and echocardiography will be applied.